B58.2 Toxoplasma meningoencephalitis

Name of the Condition

• Toxoplasma meningoencephalitis

Summary

Toxoplasma meningoencephalitis is a neurological manifestation of infection with the protozoan parasite Toxoplasma gondii. It involves inflammation of the meninges and brain parenchyma, potentially leading to severe neurological dysfunction. The condition may present as an acute or chronic disease, with clinical severity varying based on the host's immune status and the extent of central nervous system involvement. While often asymptomatic in immunocompetent individuals, it can cause life-threatening complications in immunocompromised patients or those with congenital infection.

Causes

The condition is caused by Toxoplasma gondii, a parasite that can infect neural tissues through congenital transmission or reactivation of latent infection. Transmission occurs via ingestion of contaminated food or water, contact with cat feces containing oocysts, or consumption of undercooked meat harboring tissue cysts. In the brain, the parasite can invade neural and glial tissues, triggering inflammatory responses that may lead to edema, necrosis, or mass lesions.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Congenital infection acquired from an infected mother during pregnancy.
• Exposure to cat feces or contaminated soil.
• Consumption of undercooked or raw meat, particularly pork, lamb, or venison.
• Advanced age or systemic immunosuppression.

Symptoms

• Headache, fever, and altered mental status.
• Seizures, confusion, or personality changes.
• Focal neurological deficits, such as weakness or sensory loss.
• Meningeal signs, including neck stiffness or photophobia.
• Visual disturbances or cranial nerve palsies in severe cases.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging studies (e.g., MRI or CT of the brain), and laboratory testing. Cerebrospinal fluid analysis may show lymphocytic pleocytosis, elevated protein, or positive PCR for Toxoplasma gondii DNA. Serological tests (e.g., IgG/IgM antibodies) can support acute or chronic infection, while brain biopsy may be considered in atypical cases. Imaging often reveals characteristic lesions, such as ring-enhancing masses or diffuse encephalitis.

Treatment Options

Treatment depends on the patient's immune status and disease severity. Immunocompetent patients with mild disease may require supportive care, while immunocompromised individuals typically receive combination therapy with pyrimethamine, sulfadiazine, and leucovorin. Adjunctive corticosteroids may be used to reduce inflammation. Lifelong suppressive therapy is often necessary for patients with HIV/AIDS or other chronic immunosuppression to prevent relapse.

Prognosis and Follow-Up

Prognosis varies widely based on immune status, timeliness of treatment, and extent of neurological damage. Immunocompetent patients generally have a favorable outcome with appropriate therapy, whereas immunocompromised patients face higher risks of severe complications or death. Follow-up includes monitoring for treatment response, managing side effects, and assessing for relapse. Neurological rehabilitation may be required for residual deficits.

Complications

• Seizure disorders or epilepsy.
• Permanent neurological deficits, such as cognitive impairment or motor dysfunction.
• Hydrocephalus due to obstructive lesions.
• Recurrent infection in immunocompromised hosts.
• Death in untreated or severe cases.

Lifestyle & Prevention

• Avoid undercooked meat and unpasteurized dairy products.
• Practice good hygiene when handling cat litter or gardening.
• Immunocompromised individuals should avoid high-risk exposures (e.g., cat feces).
• Pregnant individuals should avoid contact with potentially contaminated environments.
• Ensure food safety measures, such as thorough cooking and handwashing.

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe headache, confusion, seizures, or focal neurological deficits. Immunocompromised patients or those with a history of toxoplasmosis should consult a healthcare provider for worsening symptoms or suspected relapse. Prompt evaluation is critical to prevent irreversible neurological damage.

Tips for Medical Coders

Document the underlying immune status (e.g., HIV/AIDS, transplant) and any congenital or reactivated infection, as these impact coding specificity. Include details of diagnostic testing (e.g., PCR, serology) and treatment regimens to support code assignment. Note the presence of complications (e.g., seizures, hydrocephalus) for additional coding if applicable. Ensure documentation aligns with clinical guidelines for neurological manifestations of toxoplasmosis.